44 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... Empagliflozin lowered CV ... SGLT2i in HF and CKD ... visualabstract #table ... #CVD #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Summary Table ... major adverse CV ... major adverse CV ... Improved outcomes in CKD ... #comparison #management
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... Kidney Disease (CKD ... per 1.73 m2 • Stable ... damage #AKI #CKD ... #nephrology #acute
Causes of Polyneuropathy - Differential Diagnosis Algorithm
 • Metabolic: DM, Hypothyroidism, CKD, Cirrhosis, Nutritional deficiency
 •
Hypothyroidism, CKD ... Paraneoplastic, CTD ... Mitochondrial issues - VA ... Algorithm #causes #neurology
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
medications in CKD ... Spironolactone MCW Nephrology ... Pharmacokinetics #halflife #comparison ... #table
POCUS Echocardiography - Table of Cardiac Views and Windows
 • Parastemal Long-Axis View (PLAX)
 • Parasternal
Echocardiography - Table ... -Chamber View (A4C ... Inferior Vena Cava ... Orientations #Atlas #Map #Comparison ... #Table #Echocardiography
Diabetes – diabetic nephropathy
Majority of the literature in the area is applied to the diabetic nephropathy
Diabetesdiabetic ... applied to the diabetic ... primary cause of diabetic ... Pathophysiology #Nephrology ... #CKD #Diabetic
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... summarizes the A1C ... pharmacotherapy #table ... #comparison #management
Characteristics of Common Lipid Disorders
Polygenic hypercholesterolemia
Atherogenic dyslipidemia
 • Frequently accompanied by central obesity or diabetes
Familial hypercholesterolemia,
central obesity or diabetes ... Family history of CHD ... Family history, CHD ... disorders #diseases #comparison ... #table #defects